Ernexa Therapeutics (ERNA) EBIT Margin (2009 - 2026)
Ernexa Therapeutics (ERNA) reported EBIT Margin of -14194.74% for Q4 2024, down 2429.43 percentage points from -11765.31% a year earlier and down 13730.88 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) EBIT Margin (2009 - 2026) Analysis & Trends
For FY2024, Ernexa Therapeutics posted EBIT Margin of -2612.33%, up 18522.67 percentage points from FY2023.
- EBIT Margin has a five-year change of -2603.44 percentage points (FY2019 to FY2024).
- By year, EBIT Margin came in at -21135.00% in FY2023 and -124.97% in FY2020 (-116.07 pp).
- The Q4 2024 figure ranks as the lowest quarterly EBIT Margin in data going back to Q2 2010.
- Per Business Quant data, the three quarters before Q4 2024 came in at -463.86% (Q3 2024), -10491.49% (Q2 2024) and -12312.77% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | -6,102.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6,102.04% |
| Jun 30, 2026 | -7,461.82% |
| Mar 31, 2026 | -12,704.55% |
| Sep 30, 2025 | -6,429.03% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -14,194.74% |
| Sep 30, 2024 | -463.86% |
| Jun 30, 2024 | -10,491.49% |
| Mar 31, 2024 | -12,312.77% |
| Dec 31, 2023 | -11,765.31% |
| Sep 30, 2023 | -10,794.12% |
| Jun 30, 2023 | -18,954.17% |
| Dec 31, 2020 | -187.80% |
| Sep 30, 2020 | -135.92% |
| Jun 30, 2020 | -267.80% |
| Mar 31, 2020 | -42.38% |
| Dec 31, 2019 | -23.74% |
| Sep 30, 2019 | -6.90% |
| Jun 30, 2019 | -0.04% |
| Mar 31, 2019 | -4.49% |
API Access
Ernexa Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();